Celularity Stock Analysis

Celularity Stock Analysis Notes

About 56.0% of the company shares are held by company insiders. The book value of Celularity was currently reported as 0.79. The company recorded a loss per share of 108.86. Celularity had not issued any dividends in recent years. The entity had 1:10 split on the 29th of February 2024. Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. The company was incorporated in 2016 and is headquartered in Florham Park, New Jersey. Celularity operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 225 people. For more info on Celularity please contact Robert MD at 908 768 2170 or go to https://www.celularity.com.

Celularity Investment Alerts

Celularity Upcoming and Recent Events

Celularity Largest EPS Surprises

View All Earnings Estimates

Celularity Stock Institutional Investors

Note, although Celularity's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Celularity Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 39.76 M.

Celularity Profitablity

The company has Profit Margin (PM) of (0.73) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.24) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.24.

Management Efficiency

Celularity has return on total asset (ROA) of (0.1745) % which means that it has lost $0.1745 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.475) %, meaning that it created substantial loss on money invested by shareholders. Celularity's management efficiency ratios could be used to measure how well Celularity manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to -1.71 in 2025. Return On Capital Employed is likely to gain to -2.74 in 2025. Liabilities And Stockholders Equity is likely to gain to about 308.3 M in 2025, whereas Total Current Liabilities is likely to drop slightly above 39.3 M in 2025.

Technical Drivers

As of the 20th of March, Celularity shows the Mean Deviation of 5.08, standard deviation of 7.56, and Risk Adjusted Performance of (0.02). Celularity technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Celularity Price Movement Analysis

Celularity Insider Trading Activities

Celularity Outstanding Bonds

Celularity Predictive Daily Indicators

Celularity Forecast Models

Celularity's time-series forecasting models are one of many Celularity's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Celularity's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Celularity prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Celularity shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Celularity. By using and applying Celularity Stock analysis, traders can create a robust methodology for identifying Celularity entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Celularity analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Celularity analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Celularity stock analysis indicators help investors evaluate how Celularity stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Celularity shares will generate the highest return on investment. By understating and applying Celularity stock analysis, traders can identify Celularity position entry and exit signals to maximize returns.

When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.